Edesa Biotech (EDSA) Tax Provisions (2013 - 2025)
Edesa Biotech (EDSA) posted Tax Provisions of $199200.0 for Q3 2025, up 24800.0% sequentially from $800.0 in Q1 2025, and up 36.25% YoY from $146200.0 in Q3 2024.
Edesa Biotech (EDSA) Tax Provisions (2013 - 2025) Analysis & Trends
Edesa Biotech has reported Tax Provisions for 11 years, with the latest figure at $199200.0 in Q3 2025.
- Quarterly Tax Provisions rose 36.25% year-over-year to $199200.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $346200.0 (down 28.65% YoY) and the FY2025 annual result came in at $200000.0, up 36.05% from the prior year.
- Tax Provisions climbed to $199200.0 in Q3 2025 per EDSA's latest filing, from $800.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $338200.0 in Q3 2023 and troughed at -$4.7 million in Q3 2022.
- A 5-year average of -$750000.0 and a median of $800.0 in 2021 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions soared 107.27% in 2023, then tumbled 56.77% in 2024.
- Over 5 years, Tax Provisions stood at -$3.5 million in 2021, then slumped by 31.5% to -$4.7 million in 2022, then jumped by 107.27% to $338200.0 in 2023, then sank by 56.77% to $146200.0 in 2024, then soared by 36.25% to $199200.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $199200.0, $800.0, and $146200.0 for Q3 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 199,200.00 |
| Mar 31, 2025 | 800.00 |
| Sep 30, 2024 | 146,200.00 |
| Mar 31, 2024 | 800.00 |
| Sep 30, 2023 | 338,200.00 |
| Mar 31, 2023 | 800.00 |
| Sep 30, 2022 | -4.65 Mn |
| Mar 31, 2022 | 800.00 |
| Sep 30, 2021 | -3.54 Mn |
| Mar 31, 2021 | 800.00 |
| Dec 31, 2019 | 800.00 |
| Dec 31, 2017 | 800.00 |
| Dec 31, 2016 | 800.00 |
| Dec 31, 2015 | 7,200.00 |
| Sep 30, 2015 | 9,000.00 |
| Jun 30, 2015 | 9,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Dec 31, 2014 | 9,800.00 |
| Dec 31, 2013 | 800.00 |